MIC
ABBV icon

Mubadala Investment Company’s AbbVie ABBV Stock Holding History

Mubadala Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.31M Buy
19,802
+2,804
+16% +$622K 0.02% 34
2025
Q4 		$3.88M Buy
+16,998
New +$3.87M 0.02% 38
2025
Q3 		– Sell
-18,664
Closed -$3.46M – 59
2025
Q2 		$3.46M Sell
18,664
-3,184
-15% -$592K 0.02% 32
2025
Q1 		$4.58M Buy
21,848
+2,063
+10% +$401K 0.03% 10
2024
Q4 		$3.52M Buy
+19,785
New +$3.64M 0.02% 28

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mubadala Investment Company's ABBV Position: Q1 2026 in Review

Mubadala Investment Company increased its AbbVie (ABBV) stake by 16% in Q1 2026, buying an estimated $622K and bringing the position to 19,802 shares worth $4.31M. The position accounts for 0.02% of the portfolio, ranked #34.

Mubadala Investment Company first reported a position in ABBV in Q4 2024 and has held it in 5 quarters since. The position peaked at $4.58M in Q1 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Mubadala Investment Company held 19,802 shares of AbbVie worth $4.31M as of Q1 2026.
  • Mubadala Investment Company bought 2,804 AbbVie shares in Q1 2026, an estimated $622K.
  • AbbVie made up 0.02% of Mubadala Investment Company's portfolio in Q1 2026, its #34 holding.
  • Mubadala Investment Company first reported a position in AbbVie in Q4 2024 and has held it in 5 quarters since.
  • Mubadala Investment Company's AbbVie position peaked at $4.58M in Q1 2025.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Mubadala Investment Company's 13F filing for Q1 2026, filed 15 May 2026.